Singleton W, Saxton C A, Hernandez J, Prichard B N
J Cardiovasc Pharmacol. 1982;4 Suppl 1:S145-51. doi: 10.1097/00005344-198200041-00029.
The effects of 3 quinazoline alpha-adrenoreceptor antagonists, prazosin, trimazosin, and UK-33,274, on lying blood pressure (BP), BP response to 60 degrees tilt, pressor response to noradrenaline, phenylephrine, and exercise (isometric and dynamic) were measured in a double-blind study in 6 volunteers. There was no difference between the effects of prazosin 2 mg, trimazosin 200 mg, and UK-33,274 4 mg on lying and tilted BP or on BP response to exercise. All three drugs competitively antagonised the systolic and diastolic pressor effect of phenylephrine and the systolic pressor effect of noradrenaline. Prazosin and UK 33,274 completely suppressed the diastolic pressor effect of noradrenaline and produced an increase rather than a decrease in heart rate (HR). Trimazosin produced a parallel shift in noradrenaline dose response curves for diastolic pressure ahd HR. Prazosin and UK-33,274, but not trimazosin, therefore, produced effects unlike those previously described with alpha-blockers, e.g., phentolamine. The difference between antagonism of the systolic and diastolic effects suggests that the resistance component of the noradrenaline pressor effect, mediated principally via alpha 1-stimulation, is more effectively blocked than the cardiac component, which depends on venous return and alpha 2-mediated venoconstriction. Prazosin and UK-33,274 are clearly alpha 1-selective. Trimazosin is less selective.
在一项针对6名志愿者的双盲研究中,测量了3种喹唑啉α-肾上腺素能受体拮抗剂(哌唑嗪、曲马唑嗪和UK-33,274)对卧位血压(BP)、BP对60度倾斜的反应、对去甲肾上腺素、去氧肾上腺素和运动(等长运动和动态运动)的升压反应的影响。2毫克哌唑嗪、200毫克曲马唑嗪和4毫克UK-33,274对卧位和倾斜位BP或对运动的BP反应的影响之间没有差异。所有三种药物均竞争性拮抗去氧肾上腺素的收缩压和舒张压升压作用以及去甲肾上腺素的收缩压升压作用。哌唑嗪和UK-33,274完全抑制了去甲肾上腺素的舒张压升压作用,并使心率(HR)增加而非降低。曲马唑嗪使去甲肾上腺素舒张压剂量反应曲线和HR产生平行移动。因此,哌唑嗪和UK-33,274产生的作用与先前描述的α阻滞剂(如酚妥拉明)不同。收缩压和舒张压作用拮抗之间的差异表明,主要通过α1刺激介导的去甲肾上腺素升压作用的阻力成分比依赖静脉回流和α2介导的静脉收缩的心脏成分更有效地被阻断。哌唑嗪和UK-33,274显然是α1选择性的。曲马唑嗪的选择性较低。